SUZHOU ALPHAMAB CO., LTD.
8Patents
8Active
8Granted
47Portfolio score
Filing activity: Jul 25, 2013 → Oct 7, 2021
Most-cited patents
| Patent | Title | Area | Cited by | Status |
|---|---|---|---|---|
| US11091549B2 | Single domain antibody and derivative proteins thereof against CTLA4 | Emerging Cross-Sectional Technologies | 2 | Active |
| US11225522B2 | Single domain antibody and derivative proteins thereof against programmed death-ligand (PDL1) | Chemistry; Metallurgy | 2 | Active |
| US11168149B2 | Heterodimer molecule based on CH3 domain, and preparation method and use thereof | Chemistry; Metallurgy | 1 | Active |
| US9969786B2 | Trophic hormone fusion protein, preparation method and application thereof | Chemistry; Metallurgy | 1 | Active |
| US11377497B2 | PD-L1 binding polypeptide or composite | Chemistry; Metallurgy | 0 | Active |
| US12281177B2 | Heterodimer molecule based on CH3 domain, and preparation method and use thereof | Chemistry; Metallurgy | 0 | Active |
| US11912768B2 | Single domain antibody and derivative proteins thereof against CTLA4 | Emerging Cross-Sectional Technologies | 0 | Active |
| US9708389B2 | Method for preparing homodimer protein mixture by using charge repulsion effect | Chemistry; Metallurgy | 0 | Active |
Source: USPTO / EPO open patent data. Counts and citation impact are objective bibliographic measures.